NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims against Health Insurance Innovations, Inc. (NASDAQ:HIIQ). Our investigation concerns possible breaches of fiduciary duty by certain officers and directors of the Company.
On September 11, 2017, Seeking Alpha published an article asserting that: (1) in June 2017, the Company was rejected for licensure in its home state of Florida, as the regulator uncovered multiple undisclosed legal actions against multiple Health Insurance Innovations insiders; and (2) the Company privately warned the regulator of a disastrous “domino effect” of denials spreading to other stated where Health Insurance Innovations does business, yet failed to disclose this anticipated impact to investors in its regulatory filings. Following this news, the stock price of the Company fell $6.55 per share, or almost 22%.
A number of class actions accusing Health Insurance Innovations’ executives of securities fraud have been filed in federal courts.
If you purchased or otherwise acquired Health Insurance Innovations shares and suffered a loss, continue to hold shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Health Insurance Innovations, Inc., please go to http://www.bespc.com/healthinsuranceinnovationsinc. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.